P

Inventor

TSUCHIYA MASAYUKI

JP66 patents
⚠️ This page may combine multiple inventors who share the name “TSUCHIYA MASAYUKI”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

CHUGAI PHARMACEUTICAL CO LTD

28 patents
US5856135AJan 5, 1999

Reshaped human antibody to human interleukin-6

CHUGAI PHARMACEUTICAL CO LTD155 citations99
US7479543B2Jan 20, 2009

Reshaped human antibody to human interleukin-6 receptor

CHUGAI PHARMACEUTICAL CO LTD239 citations98
US7052873B2May 30, 2006

Natural human antibody

CHUGAI PHARMACEUTICAL CO LTD151 citations98
US6121423ASep 19, 2000

Reshaped human antibody to human interleukin-6

CHUGAI PHARMACEUTICAL CO LTD121 citations98
US5817790AOct 6, 1998

Reshaped human antibody to human interleukin-6 receptor

CHUGAI PHARMACEUTICAL CO LTD233 citations98
US5795965AAug 18, 1998

Reshaped human to human interleukin-6 receptor

CHUGAI PHARMACEUTICAL CO LTD368 citations98
US6608188B1Aug 19, 2003

CRT-1 gene having reverse transcriptase motif

CHUGAI PHARMACEUTICAL CO LTD40 citations96
US6245894B1Jun 12, 2001

Reshaped human antibody to human interleukin-8

CHUGAI PHARMACEUTICAL CO LTD65 citations96
US6024956AFeb 15, 2000

Method to treat inflammation with humanized anti-IL-8-antibodies

CHUGAI PHARMACEUTICAL CO LTD59 citations96
US5994524ANov 30, 1999

Polynucleotides which encode reshaped IL-8-specific antibodies and methods to produce the same

CHUGAI PHARMACEUTICAL CO LTD72 citations96
US6989244B1Jan 24, 2006

Method for screening compounds inhibiting signal transduction through inflammatory cytokines

CHUGAI PHARMACEUTICAL CO LTD71 citations95
US6214973B1Apr 10, 2001

Reshaped human antibody to human medulloblastoma cells

CHUGAI PHARMACEUTICAL CO LTD26 citations92
US6699974B2Mar 2, 2004

Reshaped human anti-HM 1.24 antibody

CHUGAI PHARMACEUTICAL CO LTD32 citations91
US7696325B2Apr 13, 2010

Polypeptide inducing apoptosis

CHUGAI PHARMACEUTICAL CO LTD22 citations90
US7744880B2Jun 29, 2010

Cell growth inhibitors containing anti-glypican 3 antibody

CHUGAI PHARMACEUTICAL CO LTD13 citations84
US7691588B2Apr 6, 2010

Ligand having agonistic activity to mutated receptor

CHUGAI PHARMACEUTICAL CO LTD14 citations84
US6551840B2Apr 22, 2003

Method of screening TGF-β-inhibiting substances

CHUGAI PHARMACEUTICAL CO LTD16 citations84
US8034903B2Oct 11, 2011

Degraded TPO agonist antibody

CHUGAI PHARMACEUTICAL CO LTD8 citations83
US8008073B2Aug 30, 2011

Anti-Mpl antibodies

CHUGAI PHARMACEUTICAL CO LTD12 citations83
US7993642B2Aug 9, 2011

Anti-MPL antibodies

CHUGAI PHARMACEUTICAL CO LTD11 citations83
US7709615B2May 4, 2010

Polynucleotides encoding anti-ganglioside antibodies

CHUGAI PHARMACEUTICAL CO LTD11 citations82
US6068840AMay 30, 2000

Recombinant CDR-grafted and chimeric anti-IL-8 antibodies containing CDRs or the variable region from the mouse monoclonal antibody, WS-4

CHUGAI PHARMACEUTICAL CO LTD11 citations73
US6048972AApr 11, 2000

Recombinant materials for producing humanized anti-IL-8 antibodies

CHUGAI PHARMACEUTICAL CO LTD6 citations73
US6610485B1Aug 26, 2003

Methods for isolating a cDNA encoding a membrane-bound protein

CHUGAI PHARMACEUTICAL CO LTD8 citations71
US6451617B1Sep 17, 2002

Method of screening TGF-β inhibitory substances

CHUGAI PHARMACEUTICAL CO LTD4 citations62
US6908750B2Jun 21, 2005

Gene encoding HM1.24 antigen protein and promoter thereof

CHUGAI PHARMACEUTICAL CO LTD4 citations61
US6613546B1Sep 2, 2003

Gene encoding HM1.24 antigen protein and promoter thereof

CHUGAI PHARMACEUTICAL CO LTD4 citations61
US8008076B2Aug 30, 2011

Method of producing a nucleic acid encoding an antibody

CHUGAI PHARMACEUTICAL CO LTD3 citations59

HITACHI LTD

5 patents

HONDA MOTOR CO LTD

4 patents

CANON KK

4 patents

KIKUCHI YASUFUMI

2 patents

TSUCHIYA MASAYUKI

1 patent

ABURATANI HIROYUKI

1 patent

OZAKI SHUJI

1 patent

IRIE REIKO

1 patent

NGK INSULATORS LTD

1 patent

TOYODA TETSUYA

1 patent

Chugai Seiyako Kabushiki Kaisha

1 patent

Showing the top 50 of 66 patents by PatentIndex Score.